Stay updated with breaking news from Semarion Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a £2.14 million s
Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors.
Funding will support recruitment, commercial partnerships, and further development of Semarion's SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel